Global Veterinary mRNA Vaccines Market Research Report 2026(Status and Outlook)
Veterinary mRNA vaccines are a new generation of vaccines designed to protect animals from infectious diseases using messenger RNA (mRNA) technology. These vaccines work by delivering synthetic mRNA into animal cells, instructing them to produce specific antigens that trigger an immune response without using live pathogens. Compared to traditional vaccines, mRNA vaccines offer advantages such as faster development, adaptability to emerging diseases, and the ability to target multiple pathogens. They are being developed for livestock, poultry, and companion animals to combat diseases like avian influenza, swine fever, and canine influenza, improving animal health and food security.Compared to traditional vaccines, mRNA vaccines have demonstrated revolutionary advantages in the field of animal health. This technology introduces mRNA sequences encoding specific antigens of pathogens into animal cells, directing the cells to synthesize antigen proteins and thus stimulating an immune response. This mechanism avoids the production complexities of traditional inactivated or live attenuated vaccines while possessing the ability to rapidly respond to emerging diseases. This technological characteristic is particularly important in the context of frequent outbreaks of major animal diseases such as African swine fever and avian influenza. The animal mRNA vaccine market is in the early stages of explosive growth, with the first peak in market launches expected between 2026 and 2028.In terms of product type, animal mRNA vaccines mainly fall into two categories: non-replicating mRNA vaccines and self-replicating mRNA vaccines. Non-replicating mRNA vaccines have a simple structure, flexible sequence design, rapid antigen replacement (e.g., to address viral mutations), mature production processes (in vitro transcription + LNP encapsulation), no risk of genome integration, and no infectious particles; the toxicity of LNP delivery systems is controllable, and clinical adverse reactions are mainly mild to moderate (e.g., local pain, fever). Currently, most domestic companies pursue rapid market launch and development of multivalent vaccines, which are primarily non-replicating mRNA vaccines. In contrast, self-amplifying mRNA vaccines use replicase to amplify the mRNA copy number, and ng-level doses can induce a strong immune response (antibody titers increased more than 10-fold in animal experiments). Antigen expression lasts for several weeks, and a single dose can provide long-term protection.
The global Veterinary mRNA Vaccines market size was estimated at USD 81.02 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 41.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Veterinary mRNA Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Veterinary mRNA Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Veterinary mRNA Vaccines market.
Global Veterinary mRNA Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck Animal Health
Ceva Animal Health
Tiba Biotechnology
Jinyu Biotechnology
Harbin Enwei Biological Pharmaceutical
Shanghai Rnacure Biopharma
Ruipu Biotechnology
Jiangsu Synthgene Biotechnology
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Market Segmentation (by Type)
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market Segmentation (by Application)
Pigs
Poultry
Ruminants
Companion Animals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Veterinary mRNA Vaccines Market
Overview of the regional outlook of the Veterinary mRNA Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary mRNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Veterinary mRNA Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Veterinary mRNA Vaccines market size was estimated at USD 81.02 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 41.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Veterinary mRNA Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Veterinary mRNA Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Veterinary mRNA Vaccines market.
Global Veterinary mRNA Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck Animal Health
Ceva Animal Health
Tiba Biotechnology
Jinyu Biotechnology
Harbin Enwei Biological Pharmaceutical
Shanghai Rnacure Biopharma
Ruipu Biotechnology
Jiangsu Synthgene Biotechnology
Genvax Technologies
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Market Segmentation (by Type)
Non-replicating mRNA Vaccine
Self-amplifying mRNA Vaccine
Market Segmentation (by Application)
Pigs
Poultry
Ruminants
Companion Animals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Veterinary mRNA Vaccines Market
Overview of the regional outlook of the Veterinary mRNA Vaccines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary mRNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Veterinary mRNA Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Veterinary mRNA Vaccines
1.2 Key Market Segments
1.2.1 Veterinary mRNA Vaccines Segment by Type
1.2.2 Veterinary mRNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VETERINARY MRNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Veterinary mRNA Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Veterinary mRNA Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VETERINARY MRNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Veterinary mRNA Vaccines Product Life Cycle
3.3 Global Veterinary mRNA Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Veterinary mRNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Veterinary mRNA Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Veterinary mRNA Vaccines Market Competitive Situation and Trends
3.8.1 Veterinary mRNA Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Veterinary mRNA Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VETERINARY MRNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Veterinary mRNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VETERINARY MRNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Veterinary mRNA Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Veterinary mRNA Vaccines Market
5.7 ESG Ratings of Leading Companies
6 VETERINARY MRNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Veterinary mRNA Vaccines Market Size by Type (2020-2025)
6.4 Global Veterinary mRNA Vaccines Price by Type (2020-2025)
7 VETERINARY MRNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary mRNA Vaccines Market Sales by Application (2020-2025)
7.3 Global Veterinary mRNA Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
8 VETERINARY MRNA VACCINES MARKET SALES BY REGION
8.1 Global Veterinary mRNA Vaccines Sales by Region
8.1.1 Global Veterinary mRNA Vaccines Sales by Region
8.1.2 Global Veterinary mRNA Vaccines Sales Market Share by Region
8.2 Global Veterinary mRNA Vaccines Market Size by Region
8.2.1 Global Veterinary mRNA Vaccines Market Size by Region
8.2.2 Global Veterinary mRNA Vaccines Market Size by Region
8.3 North America
8.3.1 North America Veterinary mRNA Vaccines Sales by Country
8.3.2 North America Veterinary mRNA Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Veterinary mRNA Vaccines Sales by Country
8.4.2 Europe Veterinary mRNA Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary mRNA Vaccines Sales by Region
8.5.2 Asia Pacific Veterinary mRNA Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Veterinary mRNA Vaccines Sales by Country
8.6.2 South America Veterinary mRNA Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Veterinary mRNA Vaccines Sales by Region
8.7.2 Middle East and Africa Veterinary mRNA Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VETERINARY MRNA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Veterinary mRNA Vaccines by Region(2020-2025)
9.2 Global Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Veterinary mRNA Vaccines Production
9.4.1 North America Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Veterinary mRNA Vaccines Production
9.5.1 Europe Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Veterinary mRNA Vaccines Production (2020-2025)
9.6.1 Japan Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Veterinary mRNA Vaccines Production (2020-2025)
9.7.1 China Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.7.2 China Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck Animal Health
10.1.1 Merck Animal Health Basic Information
10.1.2 Merck Animal Health Veterinary mRNA Vaccines Product Overview
10.1.3 Merck Animal Health Veterinary mRNA Vaccines Product Market Performance
10.1.4 Merck Animal Health Business Overview
10.1.5 Merck Animal Health SWOT Analysis
10.1.6 Merck Animal Health Recent Developments
10.2 Ceva Animal Health
10.2.1 Ceva Animal Health Basic Information
10.2.2 Ceva Animal Health Veterinary mRNA Vaccines Product Overview
10.2.3 Ceva Animal Health Veterinary mRNA Vaccines Product Market Performance
10.2.4 Ceva Animal Health Business Overview
10.2.5 Ceva Animal Health SWOT Analysis
10.2.6 Ceva Animal Health Recent Developments
10.3 Tiba Biotechnology
10.3.1 Tiba Biotechnology Basic Information
10.3.2 Tiba Biotechnology Veterinary mRNA Vaccines Product Overview
10.3.3 Tiba Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.3.4 Tiba Biotechnology Business Overview
10.3.5 Tiba Biotechnology SWOT Analysis
10.3.6 Tiba Biotechnology Recent Developments
10.4 Jinyu Biotechnology
10.4.1 Jinyu Biotechnology Basic Information
10.4.2 Jinyu Biotechnology Veterinary mRNA Vaccines Product Overview
10.4.3 Jinyu Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.4.4 Jinyu Biotechnology Business Overview
10.4.5 Jinyu Biotechnology Recent Developments
10.5 Harbin Enwei Biological Pharmaceutical
10.5.1 Harbin Enwei Biological Pharmaceutical Basic Information
10.5.2 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Overview
10.5.3 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Market Performance
10.5.4 Harbin Enwei Biological Pharmaceutical Business Overview
10.5.5 Harbin Enwei Biological Pharmaceutical Recent Developments
10.6 Shanghai Rnacure Biopharma
10.6.1 Shanghai Rnacure Biopharma Basic Information
10.6.2 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Overview
10.6.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Market Performance
10.6.4 Shanghai Rnacure Biopharma Business Overview
10.6.5 Shanghai Rnacure Biopharma Recent Developments
10.7 Ruipu Biotechnology
10.7.1 Ruipu Biotechnology Basic Information
10.7.2 Ruipu Biotechnology Veterinary mRNA Vaccines Product Overview
10.7.3 Ruipu Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.7.4 Ruipu Biotechnology Business Overview
10.7.5 Ruipu Biotechnology Recent Developments
10.8 Jiangsu Synthgene Biotechnology
10.8.1 Jiangsu Synthgene Biotechnology Basic Information
10.8.2 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Overview
10.8.3 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.8.4 Jiangsu Synthgene Biotechnology Business Overview
10.8.5 Jiangsu Synthgene Biotechnology Recent Developments
10.9 Genvax Technologies
10.9.1 Genvax Technologies Basic Information
10.9.2 Genvax Technologies Veterinary mRNA Vaccines Product Overview
10.9.3 Genvax Technologies Veterinary mRNA Vaccines Product Market Performance
10.9.4 Genvax Technologies Business Overview
10.9.5 Genvax Technologies Recent Developments
10.10 Shanghai Shen Lian Biomedical
10.10.1 Shanghai Shen Lian Biomedical Basic Information
10.10.2 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Overview
10.10.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Market Performance
10.10.4 Shanghai Shen Lian Biomedical Business Overview
10.10.5 Shanghai Shen Lian Biomedical Recent Developments
10.11 Suzhou Kerui Meide Biomedical Technology
10.11.1 Suzhou Kerui Meide Biomedical Technology Basic Information
10.11.2 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Overview
10.11.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Market Performance
10.11.4 Suzhou Kerui Meide Biomedical Technology Business Overview
10.11.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
11 VETERINARY MRNA VACCINES MARKET FORECAST BY REGION
11.1 Global Veterinary mRNA Vaccines Market Size Forecast
11.2 Global Veterinary mRNA Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Veterinary mRNA Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Veterinary mRNA Vaccines Market Size Forecast by Region
11.2.4 South America Veterinary mRNA Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Veterinary mRNA Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Veterinary mRNA Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Veterinary mRNA Vaccines by Type (2026-2035)
12.1.2 Global Veterinary mRNA Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Veterinary mRNA Vaccines by Type (2026-2035)
12.2 Global Veterinary mRNA Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Veterinary mRNA Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Veterinary mRNA Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Veterinary mRNA Vaccines
1.2 Key Market Segments
1.2.1 Veterinary mRNA Vaccines Segment by Type
1.2.2 Veterinary mRNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VETERINARY MRNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Veterinary mRNA Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Veterinary mRNA Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VETERINARY MRNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Veterinary mRNA Vaccines Product Life Cycle
3.3 Global Veterinary mRNA Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Veterinary mRNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Veterinary mRNA Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Veterinary mRNA Vaccines Market Competitive Situation and Trends
3.8.1 Veterinary mRNA Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Veterinary mRNA Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VETERINARY MRNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Veterinary mRNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VETERINARY MRNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Veterinary mRNA Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Veterinary mRNA Vaccines Market
5.7 ESG Ratings of Leading Companies
6 VETERINARY MRNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Veterinary mRNA Vaccines Market Size by Type (2020-2025)
6.4 Global Veterinary mRNA Vaccines Price by Type (2020-2025)
7 VETERINARY MRNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary mRNA Vaccines Market Sales by Application (2020-2025)
7.3 Global Veterinary mRNA Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
8 VETERINARY MRNA VACCINES MARKET SALES BY REGION
8.1 Global Veterinary mRNA Vaccines Sales by Region
8.1.1 Global Veterinary mRNA Vaccines Sales by Region
8.1.2 Global Veterinary mRNA Vaccines Sales Market Share by Region
8.2 Global Veterinary mRNA Vaccines Market Size by Region
8.2.1 Global Veterinary mRNA Vaccines Market Size by Region
8.2.2 Global Veterinary mRNA Vaccines Market Size by Region
8.3 North America
8.3.1 North America Veterinary mRNA Vaccines Sales by Country
8.3.2 North America Veterinary mRNA Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Veterinary mRNA Vaccines Sales by Country
8.4.2 Europe Veterinary mRNA Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Veterinary mRNA Vaccines Sales by Region
8.5.2 Asia Pacific Veterinary mRNA Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Veterinary mRNA Vaccines Sales by Country
8.6.2 South America Veterinary mRNA Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Veterinary mRNA Vaccines Sales by Region
8.7.2 Middle East and Africa Veterinary mRNA Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VETERINARY MRNA VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Veterinary mRNA Vaccines by Region(2020-2025)
9.2 Global Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Veterinary mRNA Vaccines Production
9.4.1 North America Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Veterinary mRNA Vaccines Production
9.5.1 Europe Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Veterinary mRNA Vaccines Production (2020-2025)
9.6.1 Japan Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Veterinary mRNA Vaccines Production (2020-2025)
9.7.1 China Veterinary mRNA Vaccines Production Growth Rate (2020-2025)
9.7.2 China Veterinary mRNA Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck Animal Health
10.1.1 Merck Animal Health Basic Information
10.1.2 Merck Animal Health Veterinary mRNA Vaccines Product Overview
10.1.3 Merck Animal Health Veterinary mRNA Vaccines Product Market Performance
10.1.4 Merck Animal Health Business Overview
10.1.5 Merck Animal Health SWOT Analysis
10.1.6 Merck Animal Health Recent Developments
10.2 Ceva Animal Health
10.2.1 Ceva Animal Health Basic Information
10.2.2 Ceva Animal Health Veterinary mRNA Vaccines Product Overview
10.2.3 Ceva Animal Health Veterinary mRNA Vaccines Product Market Performance
10.2.4 Ceva Animal Health Business Overview
10.2.5 Ceva Animal Health SWOT Analysis
10.2.6 Ceva Animal Health Recent Developments
10.3 Tiba Biotechnology
10.3.1 Tiba Biotechnology Basic Information
10.3.2 Tiba Biotechnology Veterinary mRNA Vaccines Product Overview
10.3.3 Tiba Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.3.4 Tiba Biotechnology Business Overview
10.3.5 Tiba Biotechnology SWOT Analysis
10.3.6 Tiba Biotechnology Recent Developments
10.4 Jinyu Biotechnology
10.4.1 Jinyu Biotechnology Basic Information
10.4.2 Jinyu Biotechnology Veterinary mRNA Vaccines Product Overview
10.4.3 Jinyu Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.4.4 Jinyu Biotechnology Business Overview
10.4.5 Jinyu Biotechnology Recent Developments
10.5 Harbin Enwei Biological Pharmaceutical
10.5.1 Harbin Enwei Biological Pharmaceutical Basic Information
10.5.2 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Overview
10.5.3 Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Market Performance
10.5.4 Harbin Enwei Biological Pharmaceutical Business Overview
10.5.5 Harbin Enwei Biological Pharmaceutical Recent Developments
10.6 Shanghai Rnacure Biopharma
10.6.1 Shanghai Rnacure Biopharma Basic Information
10.6.2 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Overview
10.6.3 Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Market Performance
10.6.4 Shanghai Rnacure Biopharma Business Overview
10.6.5 Shanghai Rnacure Biopharma Recent Developments
10.7 Ruipu Biotechnology
10.7.1 Ruipu Biotechnology Basic Information
10.7.2 Ruipu Biotechnology Veterinary mRNA Vaccines Product Overview
10.7.3 Ruipu Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.7.4 Ruipu Biotechnology Business Overview
10.7.5 Ruipu Biotechnology Recent Developments
10.8 Jiangsu Synthgene Biotechnology
10.8.1 Jiangsu Synthgene Biotechnology Basic Information
10.8.2 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Overview
10.8.3 Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Market Performance
10.8.4 Jiangsu Synthgene Biotechnology Business Overview
10.8.5 Jiangsu Synthgene Biotechnology Recent Developments
10.9 Genvax Technologies
10.9.1 Genvax Technologies Basic Information
10.9.2 Genvax Technologies Veterinary mRNA Vaccines Product Overview
10.9.3 Genvax Technologies Veterinary mRNA Vaccines Product Market Performance
10.9.4 Genvax Technologies Business Overview
10.9.5 Genvax Technologies Recent Developments
10.10 Shanghai Shen Lian Biomedical
10.10.1 Shanghai Shen Lian Biomedical Basic Information
10.10.2 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Overview
10.10.3 Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Market Performance
10.10.4 Shanghai Shen Lian Biomedical Business Overview
10.10.5 Shanghai Shen Lian Biomedical Recent Developments
10.11 Suzhou Kerui Meide Biomedical Technology
10.11.1 Suzhou Kerui Meide Biomedical Technology Basic Information
10.11.2 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Overview
10.11.3 Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Market Performance
10.11.4 Suzhou Kerui Meide Biomedical Technology Business Overview
10.11.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
11 VETERINARY MRNA VACCINES MARKET FORECAST BY REGION
11.1 Global Veterinary mRNA Vaccines Market Size Forecast
11.2 Global Veterinary mRNA Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Veterinary mRNA Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Veterinary mRNA Vaccines Market Size Forecast by Region
11.2.4 South America Veterinary mRNA Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Veterinary mRNA Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Veterinary mRNA Vaccines Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Veterinary mRNA Vaccines by Type (2026-2035)
12.1.2 Global Veterinary mRNA Vaccines Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Veterinary mRNA Vaccines by Type (2026-2035)
12.2 Global Veterinary mRNA Vaccines Market Forecast by Application (2026-2035)
12.2.1 Global Veterinary mRNA Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Veterinary mRNA Vaccines Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Veterinary mRNA Vaccines Market Size by Type (M USD)
Table 4. Global Veterinary mRNA Vaccines Market Size by Application
Table 5. Veterinary mRNA Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Veterinary mRNA Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Veterinary mRNA Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Veterinary mRNA Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary mRNA Vaccines as of 2025)
Table 11. Global Market Veterinary mRNA Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Veterinary mRNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Veterinary mRNA Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Veterinary mRNA Vaccines Sales by Type (K MT)
Table 27. Global Veterinary mRNA Vaccines Market Size by Type (M USD)
Table 28. Global Veterinary mRNA Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Veterinary mRNA Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Veterinary mRNA Vaccines Market Share by Type (2020-2025)
Table 32. Global Veterinary mRNA Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Veterinary mRNA Vaccines Sales (K MT) by Application
Table 34. Global Veterinary mRNA Vaccines Market Size by Application
Table 35. Global Veterinary mRNA Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Veterinary mRNA Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Veterinary mRNA Vaccines Market Share by Application (2020-2025)
Table 39. Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Veterinary mRNA Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025)
Table 44. North America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Veterinary mRNA Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Animal Health Basic Information
Table 63. Merck Animal Health Veterinary mRNA Vaccines Product Overview
Table 64. Merck Animal Health Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Animal Health Business Overview
Table 66. Merck Animal Health SWOT Analysis
Table 67. Merck Animal Health Recent Developments
Table 68. Ceva Animal Health Basic Information
Table 69. Ceva Animal Health Veterinary mRNA Vaccines Product Overview
Table 70. Ceva Animal Health Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ceva Animal Health Business Overview
Table 72. Ceva Animal Health SWOT Analysis
Table 73. Ceva Animal Health Recent Developments
Table 74. Tiba Biotechnology Basic Information
Table 75. Tiba Biotechnology Veterinary mRNA Vaccines Product Overview
Table 76. Tiba Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Tiba Biotechnology Business Overview
Table 78. Tiba Biotechnology SWOT Analysis
Table 79. Tiba Biotechnology Recent Developments
Table 80. Jinyu Biotechnology Basic Information
Table 81. Jinyu Biotechnology Veterinary mRNA Vaccines Product Overview
Table 82. Jinyu Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Jinyu Biotechnology Business Overview
Table 84. Jinyu Biotechnology Recent Developments
Table 85. Harbin Enwei Biological Pharmaceutical Basic Information
Table 86. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Overview
Table 87. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Harbin Enwei Biological Pharmaceutical Business Overview
Table 89. Harbin Enwei Biological Pharmaceutical Recent Developments
Table 90. Shanghai Rnacure Biopharma Basic Information
Table 91. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Overview
Table 92. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Shanghai Rnacure Biopharma Business Overview
Table 94. Shanghai Rnacure Biopharma Recent Developments
Table 95. Ruipu Biotechnology Basic Information
Table 96. Ruipu Biotechnology Veterinary mRNA Vaccines Product Overview
Table 97. Ruipu Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Ruipu Biotechnology Business Overview
Table 99. Ruipu Biotechnology Recent Developments
Table 100. Jiangsu Synthgene Biotechnology Basic Information
Table 101. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Overview
Table 102. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jiangsu Synthgene Biotechnology Business Overview
Table 104. Jiangsu Synthgene Biotechnology Recent Developments
Table 105. Genvax Technologies Basic Information
Table 106. Genvax Technologies Veterinary mRNA Vaccines Product Overview
Table 107. Genvax Technologies Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Genvax Technologies Business Overview
Table 109. Genvax Technologies Recent Developments
Table 110. Shanghai Shen Lian Biomedical Basic Information
Table 111. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Overview
Table 112. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shanghai Shen Lian Biomedical Business Overview
Table 114. Shanghai Shen Lian Biomedical Recent Developments
Table 115. Suzhou Kerui Meide Biomedical Technology Basic Information
Table 116. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Overview
Table 117. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 119. Suzhou Kerui Meide Biomedical Technology Recent Developments
Table 120. Global Veterinary mRNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Veterinary mRNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Veterinary mRNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Veterinary mRNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Veterinary mRNA Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Veterinary mRNA Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Veterinary mRNA Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Veterinary mRNA Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Veterinary mRNA Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Veterinary mRNA Vaccines Market Size by Type (M USD)
Table 4. Global Veterinary mRNA Vaccines Market Size by Application
Table 5. Veterinary mRNA Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Veterinary mRNA Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Veterinary mRNA Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Veterinary mRNA Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary mRNA Vaccines as of 2025)
Table 11. Global Market Veterinary mRNA Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Veterinary mRNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Veterinary mRNA Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Veterinary mRNA Vaccines Sales by Type (K MT)
Table 27. Global Veterinary mRNA Vaccines Market Size by Type (M USD)
Table 28. Global Veterinary mRNA Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Veterinary mRNA Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Veterinary mRNA Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Veterinary mRNA Vaccines Market Share by Type (2020-2025)
Table 32. Global Veterinary mRNA Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Veterinary mRNA Vaccines Sales (K MT) by Application
Table 34. Global Veterinary mRNA Vaccines Market Size by Application
Table 35. Global Veterinary mRNA Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Veterinary mRNA Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Veterinary mRNA Vaccines Market Share by Application (2020-2025)
Table 39. Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Veterinary mRNA Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025)
Table 44. North America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Veterinary mRNA Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Veterinary mRNA Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Veterinary mRNA Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Veterinary mRNA Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Veterinary mRNA Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Veterinary mRNA Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Veterinary mRNA Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Veterinary mRNA Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Animal Health Basic Information
Table 63. Merck Animal Health Veterinary mRNA Vaccines Product Overview
Table 64. Merck Animal Health Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Animal Health Business Overview
Table 66. Merck Animal Health SWOT Analysis
Table 67. Merck Animal Health Recent Developments
Table 68. Ceva Animal Health Basic Information
Table 69. Ceva Animal Health Veterinary mRNA Vaccines Product Overview
Table 70. Ceva Animal Health Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ceva Animal Health Business Overview
Table 72. Ceva Animal Health SWOT Analysis
Table 73. Ceva Animal Health Recent Developments
Table 74. Tiba Biotechnology Basic Information
Table 75. Tiba Biotechnology Veterinary mRNA Vaccines Product Overview
Table 76. Tiba Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Tiba Biotechnology Business Overview
Table 78. Tiba Biotechnology SWOT Analysis
Table 79. Tiba Biotechnology Recent Developments
Table 80. Jinyu Biotechnology Basic Information
Table 81. Jinyu Biotechnology Veterinary mRNA Vaccines Product Overview
Table 82. Jinyu Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Jinyu Biotechnology Business Overview
Table 84. Jinyu Biotechnology Recent Developments
Table 85. Harbin Enwei Biological Pharmaceutical Basic Information
Table 86. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Product Overview
Table 87. Harbin Enwei Biological Pharmaceutical Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Harbin Enwei Biological Pharmaceutical Business Overview
Table 89. Harbin Enwei Biological Pharmaceutical Recent Developments
Table 90. Shanghai Rnacure Biopharma Basic Information
Table 91. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Product Overview
Table 92. Shanghai Rnacure Biopharma Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Shanghai Rnacure Biopharma Business Overview
Table 94. Shanghai Rnacure Biopharma Recent Developments
Table 95. Ruipu Biotechnology Basic Information
Table 96. Ruipu Biotechnology Veterinary mRNA Vaccines Product Overview
Table 97. Ruipu Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Ruipu Biotechnology Business Overview
Table 99. Ruipu Biotechnology Recent Developments
Table 100. Jiangsu Synthgene Biotechnology Basic Information
Table 101. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Product Overview
Table 102. Jiangsu Synthgene Biotechnology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Jiangsu Synthgene Biotechnology Business Overview
Table 104. Jiangsu Synthgene Biotechnology Recent Developments
Table 105. Genvax Technologies Basic Information
Table 106. Genvax Technologies Veterinary mRNA Vaccines Product Overview
Table 107. Genvax Technologies Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Genvax Technologies Business Overview
Table 109. Genvax Technologies Recent Developments
Table 110. Shanghai Shen Lian Biomedical Basic Information
Table 111. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Product Overview
Table 112. Shanghai Shen Lian Biomedical Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shanghai Shen Lian Biomedical Business Overview
Table 114. Shanghai Shen Lian Biomedical Recent Developments
Table 115. Suzhou Kerui Meide Biomedical Technology Basic Information
Table 116. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Product Overview
Table 117. Suzhou Kerui Meide Biomedical Technology Veterinary mRNA Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Suzhou Kerui Meide Biomedical Technology Business Overview
Table 119. Suzhou Kerui Meide Biomedical Technology Recent Developments
Table 120. Global Veterinary mRNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Veterinary mRNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Veterinary mRNA Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Veterinary mRNA Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Veterinary mRNA Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Veterinary mRNA Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Veterinary mRNA Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Veterinary mRNA Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Veterinary mRNA Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Veterinary mRNA Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Veterinary mRNA Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Veterinary mRNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Veterinary mRNA Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Veterinary mRNA Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Veterinary mRNA Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Veterinary mRNA Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Veterinary mRNA Vaccines Product Life Cycle
Figure 13. Veterinary mRNA Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Veterinary mRNA Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Veterinary mRNA Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Veterinary mRNA Vaccines
Figure 19. Global Veterinary mRNA Vaccines Market PEST Analysis
Figure 20. Global Veterinary mRNA Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Veterinary mRNA Vaccines Market Share by Type
Figure 27. Sales Market Share of Veterinary mRNA Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Veterinary mRNA Vaccines by Type in 2025
Figure 29. Market Share of Veterinary mRNA Vaccines by Type (2020-2025)
Figure 30. Market Share of Veterinary mRNA Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Veterinary mRNA Vaccines Market Share by Application
Figure 33. Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Veterinary mRNA Vaccines Sales Market Share by Application in 2025
Figure 35. Global Veterinary mRNA Vaccines Market Share by Application (2020-2025)
Figure 36. Global Veterinary mRNA Vaccines Market Share by Application in 2025
Figure 37. Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Veterinary mRNA Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025)
Figure 40. North America Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 43. North America Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 45. U.S. Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Veterinary mRNA Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Veterinary mRNA Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Veterinary mRNA Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Veterinary mRNA Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 55. Germany Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Veterinary mRNA Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Veterinary mRNA Vaccines Market Size by Region in 2024
Figure 68. China Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 80. South America Veterinary mRNA Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 82. Brazil Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Veterinary mRNA Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Veterinary mRNA Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Veterinary mRNA Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Veterinary mRNA Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Veterinary mRNA Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Veterinary mRNA Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Veterinary mRNA Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Veterinary mRNA Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Veterinary mRNA Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Veterinary mRNA Vaccines Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Veterinary mRNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Veterinary mRNA Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Veterinary mRNA Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Veterinary mRNA Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Veterinary mRNA Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Veterinary mRNA Vaccines Product Life Cycle
Figure 13. Veterinary mRNA Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Veterinary mRNA Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Veterinary mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Veterinary mRNA Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Veterinary mRNA Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Veterinary mRNA Vaccines
Figure 19. Global Veterinary mRNA Vaccines Market PEST Analysis
Figure 20. Global Veterinary mRNA Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Veterinary mRNA Vaccines Market Share by Type
Figure 27. Sales Market Share of Veterinary mRNA Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Veterinary mRNA Vaccines by Type in 2025
Figure 29. Market Share of Veterinary mRNA Vaccines by Type (2020-2025)
Figure 30. Market Share of Veterinary mRNA Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Veterinary mRNA Vaccines Market Share by Application
Figure 33. Global Veterinary mRNA Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Veterinary mRNA Vaccines Sales Market Share by Application in 2025
Figure 35. Global Veterinary mRNA Vaccines Market Share by Application (2020-2025)
Figure 36. Global Veterinary mRNA Vaccines Market Share by Application in 2025
Figure 37. Global Veterinary mRNA Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Veterinary mRNA Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Veterinary mRNA Vaccines Market Size by Region (2020-2025)
Figure 40. North America Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 43. North America Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 45. U.S. Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Veterinary mRNA Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Veterinary mRNA Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Veterinary mRNA Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Veterinary mRNA Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 55. Germany Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Veterinary mRNA Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Veterinary mRNA Vaccines Market Size by Region in 2024
Figure 68. China Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Veterinary mRNA Vaccines Sales Market Share by Country in 2024
Figure 80. South America Veterinary mRNA Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Veterinary mRNA Vaccines Market Size by Country in 2024
Figure 82. Brazil Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Veterinary mRNA Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Veterinary mRNA Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Veterinary mRNA Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Veterinary mRNA Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Veterinary mRNA Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Veterinary mRNA Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Veterinary mRNA Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Veterinary mRNA Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Veterinary mRNA Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Veterinary mRNA Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Veterinary mRNA Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Veterinary mRNA Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Veterinary mRNA Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Veterinary mRNA Vaccines Market Share Forecast by Application (2026-2035)
